Abstract:This work presents the selection and characterization of erythropoietin (EPO)-binding cyclic peptide ligands. The sequences were selected by screening a focused library of cyclic depsipeptides cyclo[(Nα-Ac)Dap(A)-X1-X6-AE], whose structure and amino acid compositions were tailored to mimic the EPO receptor. The sequences identified through library screening were synthesized on chromatographic resin and characterized via binding-and-elution studies against EPO to select a pool of candidate ligands. Sequences with higher hydrophobicity consistently showed stronger binding to EPO, with the exception of FSLLSH, which was noted for its lower hydrophobicity and high EPO binding. Mutagenesis studies performed on FSLLSH with natural and non-natural amino acid substitutions led to the identification of critical EPO-binding determinants, and the discovery of new peptide ligands. In particular, histidine-scanning mutagenesis performed on three lead sequences yielded the discovery of variants whose EPO-binding is more pH-sensitive, which facilitates EPO recovery. Selected ligands were studied to correlate the elution yield to the salinity of the binding buffer and the elution pH. Elution yields were consistently higher when EPO binding was performed at low ionic strength. The crystal structures of lead cyclic peptides were docked in silico against EPO to estimate the binding affinity in solution. Isotherm adsorption studies performed on FSLLSH indicated that the cyclic version of the ligand (KD=0.46μM) has a higher affinity for EPO than its corresponding linear variant (KD=1.44μM). Collectively, these studies set the stage for use of the cyclic peptide ligands as EPO purification and detection tools.

Preparation of A New Erythropoietin-derived Peptide

Preparation and Identification of Carbamylated Erythropoietin

Research progress in erythropoietin mimetic peptides

Efficient preparation and PEGylation of recombinant human non-glycosylated erythropoietin expressed as inclusion body in E. coli

Synthesis and biological evaluation of (4-hydroxy-2-(substitued sulfonamido)pyrimidine-5-carbonyl)glycines as oral erythropoietin secretagogues

Erythropoietin Derived by Chemical Synthesis

EPO Mimetic Peptide Fused into PAI-1 Augments its EPO Activity

From Erythropoietin to Its Peptide Derivatives: Smaller but Stronger.

Recent Progress in the Synthesis of Homogeneous Erythropoietin (EPO) Glycoforms

Pharmacokinetics and Pharmacodynamics of Recombinant Human EPO-Fc Fusion Protein in Vivo.

PEGylation Markedly Enhances the in Vivo Potency of Recombinant Human Non-Glycosylated Erythropoietin: A Comparison with Glycosylated Erythropoietin

Detection of de-N-glycosylated EPO with SDS-PAGE: A complementary confirmation procedure for recombinant EPO in blood samples

Increased Erythropoiesis in Mice Injected With Submicrogram Quantities of Pseudouridine-containing mRNA Encoding Erythropoietin

Rapid and High-Resolution Glycoform Profiling of Recombinant Human Erythropoietin by Capillary Isoelectric Focusing with Whole Column Imaging Detection

Design, selection, and development of cyclic peptide ligands for human erythropoietin

Preparation and Content Determination of Collagen Protein Bilayer Minipellet of Recombinant Human Erythropoietin

Modeling and biological evaluation of pegmolesatide, a novel and potent erythropoiesis-stimulating agent

Screening of CHO-K1 Cell Strain for Stable Expression of Recombinant Longacting Erythropoietin

Immuno-magnetic beads-based extraction-capillary zone electrophoresis-deep UV laser-induced fluorescence analysis of erythropoietin

An Antibody CDR3-erythropoietin Fusion Protein.

Der Gewundene Pfad Zum Erythropoietin Entlang Der Grenze Von Chemie Und Biologie